Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2025-06-30 00:00:00 ET · period of report 2025-06-26 · accession 0000950170-25-091762 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-06-30 | 2025-06-26 | BBIO | Valantine Hannah | Dir | S - Sale | $44.05 | -2,289 | 2,289 | -50% | -$100.8K |
| M | 2025-06-30 | 2025-06-26 | BBIO | Valantine Hannah | Dir | S - Sale | $44.05 | -2,418 | 9,007 | -21% | -$106.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-26 | S | D | 1,891 | $44.03 | 398 | I | — | — | |
| 2 | Common | Common Stock | 2025-06-26 | S | D | 398 | $44.13 | 2,289 | I | — | — | (F2) Represents the weighted average sale price of the shares sold from $44.12 to $44.13 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2025-06-26 | S | D | 1,542 | $44.01 | 7,465 | D By Spouse | — | — | |
| 4 | Common | Common Stock | 2025-06-26 | S | D | 876 | $44.11 | 9,007 | D By Spouse | — | — | (F1) Represents the weighted average sale price of the shares sold from $44.025 to $44.14 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |